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Abstract 
Aim 
The goal of this study is to describe fetal ventriculomegaly (VM) in a developing country 
population with regards to clinical presentation, associated findings, natural history and 
outcome. 
Materials and methods 
This retrospective observational study was conducted at Tygerberg Academic Hospital, a 
secondary and tertiary referral centre in the Western Cape Province.  Data was collected from 
all pregnancies with a prenatal diagnosis of ventriculomegaly from 2013 to 2015.  The initial 
presentation and associated findings with the natural history of VM was studied and a selection 
of perinatal outcomes was measured. 
Results 
A final cohort of 252 cases was analysed: 168 mild, 42 moderate and 42 severe cases of VM. 
The median gestational age at diagnosis was 23w4d, with 48,8% diagnosed after 24w0d. Mild 
VM was more likely to be unilateral (p<0,001) and isolated (p=0,006) when compared to 
moderate and severe VM. Mild VM was associated with multiple soft markers in up to a third 
of the cases and over half of the cases normalized during pregnancy; severe VM was 
associated with multiple major anomalies in 31,0% of the cases. The majority of major 
anomalies in all 3 groups were CNS defects in 25,8% and cardiac anomalies in 10,3%. 
Termination of pregnancy was opted for in 12,5% of mild, 35,7% of moderate and 59,5% of 
severe VM cases.  
Conclusion 
VM is a common prenatal finding but, in this setting, was often diagnosed late, which limits 
options for investigation and management. Associated findings included cardiac and other 
CNS abnormalities and increased with increasing severity of VM. Aneuploidies were 
encountered within all groups. In this cohort, unilateral VM was more associated with mild VM 
and may have been due to the inclusion of borderline VM, which was shown not to be a benign 
finding. Uptake of invasive testing and of TOP was low in this community and the late diagnosis 
may have contributed to that.  
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Opsomming 
Doelwit 
Die doelwit van die studie was om fetale ventrikulomegalie (VM) te beskryf in ‘n ontwikkelende 
land, spesifiek die kliniese beeld, geassosieerde bevindinge asook uitkomste. 
 
Metodes 
Die retrospektiewe observasie studie was gedoen te Tygerberg Akademiese Hospitaal, ‘n 
sekondêre en tersiêre verwysingshospitaal in die Wes Kaap. Data is gekollekteer van alle 
swangerskappe met ‘n prenatale diagnose van fetale ventrikulomegalie vanaf 2013 tot 2015. 
Die aanvanklike kliniese beeld en geassosieerde bevindinge was bestudeer, asook sekere 
perinatale uitkomste. 
 
Resultate 
‘n Finale kohort van 252 gevalle was geanaliseer: 168 geringe, 42 matige en 42 erge gevalle 
van VM. Die mediane gestasie van diagnose was 23w4d, met 48,8% gediagnoseer na 24w0d. 
Geringe VM was meer waarskynlik unilateraal (p<0.001) asook geisoleerd (p=0,006) wanneer 
dit vergelyk word met matige en erge VM. Geringe VM was geassosieer met veelvuldige sagte 
merkers in ongeveer ‘n derde van die gevalle en meer as die helfte hiervan het genormaliseer 
tydens swangerskap. Erge VM was geassosieer met veelvuldige major abnormaliteite in 
31,0% van die gevalle. Die meerderheid van die major abnormaliteite in al 3 groepe was 
sentrale senuweestelsel defekte in 25,8% en hart-anomaliteite in 10,3%. Terminasie van 
swangerskap is ondergaan in 12,5% van geringe, 35,7% van matige en 59,5% van erge VM 
gevalle. 
 
Gevolgtrekking 
VM is nie ‘n rare prenatale bevinding nie en in die studie was dit dikwels laat gediagnoseer, 
met gevolglik beperkte ondersoeke en behandelingsopsies. Geassosieerde bevindinge, veral 
hart en sentraal senuweestelse, was algemeen en meer gesien met die toenemend graad van 
VM. Aneuploidies was in al drie groepe waargeneem. In die kohort was unilaterale VM 
frekwent, maar was meer gesien in geringe VM. Dit was heel moontlik as gevolg van die 
insluiting van grensgeval VM, wat nie ‘n onskuldige bevinding was nie. Die opname van 
invasieve toetse, insluitend terminasie van swangerskap, was laag. Laat diagnose mag 
hiertoe bygedra het. 
Stellenbosch University https://scholar.sun.ac.za
iv 
Acknowledgements 
1. Dr JL vd Merwe: for his guidance, supervision, support and patience.
2. Prof L Geerts: for her guidance and assistance.
3. Tonya Esterhuizen: for her assistance with the statistical analysis.
Stellenbosch University https://scholar.sun.ac.za
v 
 
Dedication 
To my parents. 
Thank you for all the opportunities you created for me. 
I will be forever grateful.  
Stellenbosch University https://scholar.sun.ac.za
vi 
 
Table of Contents 
Declaration          i 
Abstract          ii 
Opsomming          iii 
Acknowledgements         iv 
Dedication          v 
Table of Contents         vi 
List of figures          ix 
List of tables          x 
List of abbreviations         xi 
 
Chapter 1: Introduction        13 
1.1 Background         13 
1.2 Problem statement        14 
 
Chapter 2: Literature Review        15 
2.1 Ventriculomegaly detection/definition     15 
2.2 Ventriculomegaly: current understanding of outcomes   16 
 2.2.1 Mild VM        16 
 2.2.2 Moderate VM        17 
 2.2.3 Severe VM        18 
2.3 Ventriculomegaly: current management     19 
2.4 Ventriculomegaly in a developing country setting    23 
 2.4.1 General        23 
 2.4.2 Socio-economic       23 
 2.4.3 Communicable and infectious diseases    24 
 2.4.4 Role of invasive testing      24 
2.5 Conclusion         25 
Stellenbosch University https://scholar.sun.ac.za
vii 
 
 
Chapter 3: Methods         26 
3.1 Research Design        26 
 3.1.1 Type of study        26 
 3.1.2 Study setting        26 
 3.1.3 Study subjects       26 
3.2 Data collection        26 
3.3 Outcome measures        26 
 3.3.1 Primary outcomes included      26 
 3.3.2 Secondary outcomes included     27 
3.4 Ethics          27 
3.5 Data analysis and statistical methods     27 
 
Chapter 4: Results         28 
4.1 Baseline maternal characteristics      28 
4.2 Obstetric and medical risk profile/history     29 
4.3 Initial antenatal assessment       31 
4.4 Ventriculomegaly – associated anomalies     32 
4.5 Invasive procedures for genetic and infective markers   34 
4.6 Genetic test results        35 
4.7 Infective workup        35 
4.8 Haemorrhage         37 
4.9 Ventricle dimensions – antenatal trends     38 
4.10 Pregnancy outcomes        40 
 4.10.1 General outcomes       40 
 4.10.2 Termination of pregnancy      42 
 4.10.3 Borderline cases       44 
 4.10.4  “Apparently isolated” cases      44 
Stellenbosch University https://scholar.sun.ac.za
viii 
 
 
Chapter 5: Conclusion        46 
5.1 Summary of main findings       46 
5.2 General discussion        46 
5.3 Associations and population risk profile     47 
5.4 Evolution of VM        48 
5.5 Acceptance rates        48 
5.6 “Apparently isolated” cases       49 
5.7 Borderline measurements       51 
5.8 Limitations of study        51 
5.9 Strengths of study        51 
5.10 Conclusion and future directions      52 
 
Bibliography          53 
 
  
Stellenbosch University https://scholar.sun.ac.za
ix 
 
List of Figures 
 
Figure 1:  Study flow diagram 
Figure 2:  Symmetry and complexity of ventriculomegaly at diagnosis 
Figure 3:  Invasive testing offered and procedures performed 
Figure 4: Progression in the mild and moderate ventriculomegaly group, 
displaying the difference between the last and initial atrial width 
measurement  
Figure 5: Perinatal outcomes 
  
Stellenbosch University https://scholar.sun.ac.za
x 
 
List of Tables 
 
Table 1:  Maternal characteristics 
Table 2:  Previous obstetrical history 
Table 3:  Maternal medication use 
Table 4:  Initial antenatal assessment 
Table 5: Concurrent structural abnormality findings detected during the initial 
ultrasound assessment 
Table 6:  Chromosomal abnormalities from prenatal testing 
Table 7:  Delivery outcomes 
Table 8:  Prenatal associations in TOP cases 
Table 9:  Outcomes of apparently isolated ventriculomegaly cases 
  
Stellenbosch University https://scholar.sun.ac.za
xi 
 
List of Abbreviations 
ADHD:  Attention deficit hyperactivity disorder 
AIDS:  Acquired immunodeficiency syndrome 
ANC:  Antenatal care 
AST:   Aspartate transaminase 
AVSD:  Atrioventricular septal defect 
CD:   Caesarean delivery 
CDH:   Congenital diaphragmatic hernia 
CMA:  Chromosomal microarray 
CMV:   Cytomegalovirus 
CNS:   Central nervous system 
CPAP:  Constant positive airway pressure 
CSP:   Cavum septum pellucidum 
CTG:   Cardiotocograph 
CVS:  Chorionic villus sampling 
DM:  Diabetes Mellitus 
DORV:  Double outlet right ventricle 
FBC:  Full blood count 
GA:   Gestational age 
GDM:  Gestational Diabetes Mellitus 
GIT:   Gastro intestinal tract 
HAART: Highly active antiretroviral therapy 
HIV:   Human immunodeficiency virus 
INR:   International normalized ratio 
IOL:  Induction of labour 
IUFD:  Intrauterine fetal demise 
IUGR:  Intrauterine growth restriction 
MRI:  Magnetic resonance imaging 
Stellenbosch University https://scholar.sun.ac.za
xii 
 
MTCT:  Mother-to-child transmission 
NICU:  Neonatal intensive care unit 
NVD:   Normal vaginal delivery 
PCR:   Polymerase chain reaction 
PPROM: Preterm prelabour rupture of membranes 
RPR:   Rapid plasma reagin 
SA:  South Africa 
SES:  Socio-economic status 
TAH:  Tygerberg Academic Hospital 
TGA:   Transposition of the great arteries 
TOP:   Termination of pregnancy 
VBAC:  Vaginal birth after caesarean delivery 
VM:   Ventriculomegaly 
VSD:   Ventricular septal defect   
VZV:  Varicella Zoster virus   
Stellenbosch University https://scholar.sun.ac.za
13 
 
Chapter 1: Introduction 
1.1 Background 
 
Fetal ventriculomegaly (VM), the enlargement of the lateral ventricles of the developing fetal 
brain, is defined as a measurement of 10mm or more on an axial plane across the atrium; this 
being 4 standard deviations above the mean for the relevant gestation[1]. VM can be classified 
into mild (≥10 to <12mm), moderate (≥12 to <15mm), and severe (≥15mm)[2]. Although there 
is a wide range of reported incidences of antenatally diagnosed VM by ultrasound ranging 
from 1,5 – 22 per 1000[3,4], VM is the most common brain anomaly with a prevalence of 1/1000 
live births. This led to the recommendation that the fetal cerebral lateral ventricles should be 
measured as part of the fetal anatomical review routinely performed during the second 
trimester to screen for fetal anomalies[5]. 
VM can be isolated[6] but is frequently associated with other anomalies in 42-84% of cases[7]. 
Central nervous system (CNS) anomalies are the most prevalent associated finding as 
reported by Sparey et al[6]. Furthermore, VM is typically bilateral but there have been reports 
of unilateral cases[8-10]. A study by Mehlhorn et al[11] showed the prevalence of unilateral VM 
in 59,5% of mild VM cases.  The outcomes, especially the neurological outcomes of fetuses 
with prenatal diagnosis of VM are understandably dependent on the severity and the 
underlying cause. In “apparently” isolated mild VM, the outcomes are predominantly positive 
but neurodevelopmental delay has been reported in up to 28,6% of cases[12]. In contrast, 
severe VM is associated with a high risk of neonatal mortality[13,14] (16,2%), even in the 
absence of other prenatally detected associated anomalies[15]. A study by Breeze et al showed 
that severe VM is associated with disabilities such as isolated hemiparesis, features of 
cerebral palsy, seizures, abnormal visual development and severe learning disabilities due to 
cerebral atrophy[13]. 
Once there is a suspicion of fetal VM, current management dictates a detailed ultrasound 
anatomical review, screening for possible causative infections (i.e. CMV and toxoplasmosis) 
and offering invasive testing for especially fetal chromosome evaluation. Careful follow up is 
obligatory in on-going pregnancies to assess for progression to more severe VM[16] and to 
review for additional anomalies that can be assessed only later in the pregnancy. Ultimately 
the best timing, mode and place of delivery need to be planned and in severe or complex 
cases, with anticipated poor outcomes a termination of pregnancy can be offered[7]. 
Stellenbosch University https://scholar.sun.ac.za
14 
 
In a developing society, socioeconomic status as well as conditions such as HIV may play a 
major role in the development of VM and data regarding causes and outcomes may well differ 
from those reported from developed countries. 
 
1.2 Problem Statement 
 
Fetal VM is a relatively common finding during the routine mid-trimester structural anatomy 
ultrasound examination. In the majority of cases it can be a transient finding, almost a variant 
of normality, with a good clinical outcome. However, VM is frequently associated with other 
disorders and acute conditions and in these settings the outcomes are directly dependant on 
several factors.  
Currently the majority of publications of known outcomes and associations of fetal VM are 
from developed countries. Conditions common to developing countries like HIV and poor 
socioeconomic status play a major role in the causes, presentation and outcomes of a vast 
number of diseases. Unquestionably these conditions may have an influence on the 
developing fetal brain and specifically fetal VM as well. 
The aim of this study is to assess the clinical presentation and associated findings of fetal VM 
as well as the natural history and short-term outcomes, including rates of fetal loss, 
spontaneous miscarriage, termination of pregnancy and stillbirth rates.  
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Chapter 2: Literature Review 
2.1. Ventriculomegaly detection/definition 
 
Ventriculomegaly (VM) is defined as an enlargement of the lateral ventricles of the developing 
fetal brain. The incidence of fetal VM diagnosed antenatally by ultrasound varies from 1,48 
per 1000 (8/5400)[3] to 22 per 1000 (11/500)[4] the latter study being in a low risk population. 
Measurement of the size of the fetal cerebral lateral ventricles is recommended as part of the 
fetal anatomical review routinely performed during the second trimester to screen for fetal 
anomalies[5]. 
The ventricle is measured at the level of the atria of the lateral ventricles filled by the echogenic 
choroid plexuses, visible in an axial plane of the fetal brain also showing the frontal horns of 
the lateral ventricles and the cavum septi pellucidi[5]. The measurement is obtained at the level 
of the glomus of the choroid plexus, perpendicular to the ventricular cavity, positioning the 
callipers inside the echoes generated by the lateral walls[5]. The upper limit of the normal range 
for the ventricular atrial measurement is 10mm, this being 4 standard deviations above the 
mean for the relevant gestation[1]. VM can be classified into mild (≥10 to <12mm), moderate 
(≥12 to <15mm), and severe (≥15mm)[2]. 
VM may be an isolated finding or may be associated with other anomalies[6]. VM is considered 
‘isolated’ when the fetus does not present any other structural anomalies. The diagnosis of 
isolated VM should be made only after having carried out a complete ultrasound evaluation 
for associated intracerebral or extracerebral anomalies[17]. Yet, studies of isolated VM have 
reported that 10-13% of associated anomalies are only recognized after birth[12,18]. It is 
therefore more appropriate to use the term “apparently isolated VM” in prenatal case series. 
In 42-84% of cases, VM is associated with other anomalies[7]. These may be CNS or non-
CNS malformations, fetal infections and/or chromosomal anomalies. A study by Sparey et al 
in 1998 showed that CNS anomalies are the most prevalent associated anomalies with neural 
tube defects making up 42,4% of associated anomalies and other intracranial anomalies 
16,5%. In the same study the associated anomalies in other systems were as follows; skeletal 
25,3%, genitourinary 17,2%, facial 14,9%, gastrointestinal 17,2%, cardiovascular 12,5%, 
anterior abdominal wall defects 5,7%[7]. 
VM is typically bilateral, but there have been reports of unilateral cases[8-10]. Most authors 
agree that unilateral VM is rare, resulting in research series that are small[19] Kinzler et al[20] 
Stellenbosch University https://scholar.sun.ac.za
16 
 
described 15 fetuses with unilateral VM, with an incidence of 1 per 1411 pregnancies. Durfee 
et al[21] described 14 fetuses with asymmetrical VM, 13 of whom had unilateral VM with a 
normal contralateral ventricle. More than half of their fetuses (58%) had abnormal outcomes, 
which included several syndromes, developmental delays and intracranial haemorrhages. 
Both groups agree that fetuses with asymmetrical unilateral VM have a better prognosis than 
those with bilateral hydrocephalus but, similar to bilateral VM, the degree of unilateral VM and 
the presence of other associated anomalies, have a major impact on prognosis[19]. 
2.2. Ventriculomegaly: current understanding of outcomes 
There is wide variation in outcome of fetuses and infants with prenatally diagnosed VM. 
Probably, the first and most important question for the expectant parents is whether their child 
would be normal or otherwise stated: what is the anticipated long-term outcome? 
The neurological outcome of fetuses with prenatal diagnosis of VM predominantly depends 
on the severity of the dilatation and the underlying cause[17]. Neurological, motor and cognitive 
impairment are more likely when associated anomalies are present, with early onset, with 
persistence or progression of VM and with more severe VM[13,22,23]. In utero progression of VM 
plays an important role. A retrospective observational study[24] concluded that the progression 
of VM increased with the degree of severity, when mild, moderate and severe VM were 
compared.   
2.2.1. Mild VM 
Mild VM, especially when apparently isolated, is the most common brain abnormality 
found on prenatal ultrasound[25]. Overall the outcomes of isolated mild VM vary in different 
studies with the prevalence of neurodevelopmental delay ranging from 0% to 28,6%. 
Pagani et al[16] reported neurodevelopmental delay in 7,9%. Melchiorre et al[12] and 
Devanseelan et al[26] found the prevalence to be higher: 10,9% and 12% respectively. 
Relatively little is known about long-term outcome of children following prenatal detection 
of mild VM. Studies that have evaluated neurodevelopmental outcome in these children 
have found that about one third have some degree of neurodevelopmental abnormalities 
(mostly attention deficit hyperactivity disorder, learning disability, motor and language 
delays) that are generally mild. In one small series of nine children who had had mild, 
prenatal VM, 33% had nonverbal learning disabilities at ages 6 to 9 years[27]. 
More specifically the outcomes are mainly determined by the associated findings, the 
underlying cause and the presentation of the VM itself. A detailed anatomic ultrasound 
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evaluation must include examination for aneuploidy markers, the corpus callosum, other 
CNS abnormalities and a fetal echocardiogram. Additionally, on subsequent follow-up 
visits the fetal anatomy must be reviewed since in up to 8,6% of cases additional 
associated findings can be discovered[28]. In these cases with associated findings the 
outcomes are mainly determined by these findings and the management thereof depends 
on this. The absence of an associated anomaly also plays a role in the prognosis of 
ventricular brain enlargement[29-32]. 
Asymmetry of VM seems to be another marker as noted in a review of 366 cases where 
97% of the children had a normal development in the event of unilateral VM versus 89,6% 
in the event of bilateral enlargement[25]. In line with this remark, ventricular asymmetry 
when there is a difference of more than 2 mm between the two atrial widths[21] seems to 
be another poor prognostic marker.  
Lastly, the progression of mild VM over the course of the pregnancy seems to play a role. 
Understandably, the best outcomes seem to be in cases where the VM resolves but also 
in non-progressive non-resolving isolated mild VM cases more than 80% of infants will 
have a normal development[4,25,33,34]. 
2.2.2. Moderate VM 
The classification of VM is not always consensual as in some studies mild VM includes all 
cases of atrial measurements between 10 and 15mm[12]. In these studies, moderate VM 
was not seen as a separate entity.  Nevertheless, as in the case of mild VM, moderate VM 
can be an isolated finding, but is more often associated with other anomalies. Gaglioti et 
al[22] subdivided borderline VM into mild (<12 mm) and moderate (≥ 12mm) and found a 
significant difference in the incidence of associated malformations of 41,0% vs 75,0% 
respectively. CNS anomalies were found in 51,2% (21/41) of cases of moderate VM, 
compared to 18,7% (14/75) and 41,7% (25/60) of mild and severe cases respectively[22]. 
Sethna et al[35] found similar results in that CNS associated anomalies were more common 
in moderate VM compared to mild VM.  
The study by Gaglioti et al[22] found that in moderate VM, TOP was performed in 29,3% 
(12/41) and neonatal and infant death occurred in 7,3% (3/41) and 4,9% (2/41) 
respectively. Gaglioti only considered long-term outcome data for isolated cases since the 
outcomes were dependant on the structural and/or chromosomal anomalies. Herein, 
80,0% (8/10) of those with moderate VM were alive at 2 years of age and the 
neurodevelopmental outcome at that age was normal in 75,0% (6/8) of cases while 97,7% 
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(43/44) of mild VM cases were alive at 2 years of age, with neurodevelopmental outcome 
being normal in 93,0% (40/43). 
2.2.3. Severe VM 
Malformations are more often found in cases of severe VM[18] with up to 50% of all cases 
associated with a chromosomal and/or structural abnormality[15]. Gaglioti et al[22] confirmed 
this finding and noted that the most commonly anomalies were of the nervous system 
particularly spina bifida in 16,7% (10/60) and agenesis of corpus callosum in 18,3% 
(11/60) whereas non-CNS abnormalities were found in 16,7% (10/60) of cases. 
Outcomes in cases of severe VM are complicated by this high incidence of additional 
structural anomalies and terminations of pregnancy[13]. Prenatally detected severe VM is 
known to have a poor prognosis both in terms of survival and neurodevelopmental 
outcome[36]. This remains true even in the absence of prenatally detected associated 
anomalies[15]. Specifically, Hannon et al[15] reported a 64,3% TOP rate with a 7,0% 
neonatal death rate.  
When reflecting on ‘apparently’ isolated severe VM neurodevelopmental outcomes, 
Kennelly et al[37] reported a major morbidity in 50,0% (5/10) and a mild morbidity in 40,0% 
(4/10) of cases, with a normal outcome in only one case. Severe neurodevelopmental 
outcomes included severe developmental delay, blindness and cerebral palsy while mild 
handicap included gross motor delay, speech delay, nystagmus and squint. 
The paediatric outcomes of antenatally diagnosed cases of severe VM also appear 
guarded.  Graham et al[14] found major neurological morbidity at paediatric follow up (from 
birth to 4 years of age) in 33,3% (3/9) of survivors with isolated severe VM. Major 
neurological morbidity included cerebral palsy, epilepsy, bradyacusia with prosthesis, 
mono/bilateral blindness and mental retardation. 
 
 
2.3. Ventriculomegaly: current management  
 
Once the diagnosis of VM is made, it is essential that a detailed ultrasound anatomical review 
be done, to search for other anomalies (especially CNS and cardiac).  It is commonly accepted 
that dedicated transvaginal fetal neurosonography has a much greater diagnostic potential 
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than that of the standard transabdominal examination and is particularly helpful in the 
evaluation of complex malformations[5]. This examination however requires a degree of 
expertise that is not yet universally available[5].  
The basis of the neurosonographic examination of the fetal brain is the multiplanar approach 
that is obtained by aligning the transducer with the sutures and fontanelles of the fetal head[5]. 
Refinements in 2D fetal neurosonography have paved the way for improved visualization of 
normal CNS development and hence appreciation of abnormality[37]. A 2D ultrasound of the 
midsagittal plane of the brain has proven to be a powerful source of information and D’Addario 
et al reported a 93,1% detection rate for the cause of the ventricular dilatation by using the 
midsagittal view[38]. 
Follow-up ultrasound examinations help in assessment for regression or progression of VM 
and provides an opportunity to re-evaluate for anomalies, as follow up ultrasound 
examinations have detected fetal abnormalities not detected on the initial scan in 13% of 
cases[12]. There is no agreement regarding the timing and frequency of follow-up in fetuses 
with VM, and this will depend on the gestational age at diagnosis.  Most authors have 
suggested that the minimal time interval before performing a follow-up study should be 2 
weeks after detailed initial assessment[39]. Baffero et al[40] suggests that a follow up scan is 
indicated between 28 and 34 weeks of gestation in all cases of prenatally ultrasound diagnosis 
of VM. Sparey et al[7] states that the intervals between scans will be determined by the initial 
atrial width and subsequent progression. They reassess atrial size two weeks after the initial 
examination. If there has been a significant increase, regular follow up (every 2-4 weeks) may 
be appropriate. If the ventricular dilatation appears to be stable or resolving, less frequent 
follow up is appropriate. 
Additional imaging by fetal magnetic resonance imaging (MRI) can be used to identify 
underlying CNS abnormalities not detected by sonography[41]. The indication for fetal MRI 
remains a subject of debate, partly because of questions concerning its diagnostic accuracy 
compared to ultrasound, partly because of practical factors such as accessibility, high costs 
and available expertise[42]. Many studies have evaluated the role of fetal MRI in the discovery 
of associated anomalies in fetuses with apparently isolated VM[43]. Quahba et al[17] assessed 
123 of 167 cases of isolated mild fetal VM (diagnosed by ultrasound) by fetal MRI between 
24 and 39 weeks of gestation. The MRI showed major cerebral anomalies in 15 cases, 4 of 
them being also revealed by ultrasound monitoring. In one of the most important studies, 
Griffiths et al[6] showed additional brain abnormalities detected in 17,0% of fetuses thought to 
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have isolated VM on ultrasound only.  147 fetuses with isolated VM diagnosed by ultrasound 
were included in the study and after performing fetal MRI in all the cases, 25 fetuses had 
associated anomalies. The most common associated anomaly was agenesis of corpus 
callosum (11 cases). Simon et al[44] found that 46,0% of 52 cases of VM needed a different 
management plan after performing fetal MRI[43]. 
Most studies reported in the literature advocate the added value of MRI in cases of moderate 
and severe VM, not only to confirm the severity, but also to further detect and characterize 
additional anomalies[42]. Fetuses with severe VM had a probability ten times higher than 
fetuses with mild VM of having other abnormalities. Therefore, it could be suggested that in 
cases of moderate and severe VM, MRI of the fetus can be considered, where the expertise 
is available.  
Infection acquired in utero is a significant cause of fetal and neonatal mortality and morbidity. 
The fetal phenotype depends on the gestation at which the infection occurs. In general, 
infections in the first trimester are more likely to cause major structural malformations 
compared with infections later in pregnancy[45]. Therefore, in cases of suggestive structural 
abnormalities, screening for underlying congenital infections should be considered. The most 
common congenital infections associated with VM are toxoplasmosis and cytomegalovirus 
(CMV) infection. The prevalence of primary congenital CMV infection in newborn infants in 
the developed world is 0,25 to 2%, but the rates vary considerably among different 
populations[46]. Cerebral VM is present in 18% of the fetuses with proven intrauterine CMV 
infection[47]. The prevalence of congenital toxoplasmosis varies between 1:1000 and 1:10000 
live births.  The CNS is frequently affected, with cerebral calcification, VM and cerebrospinal 
fluid abnormalities[43]. Screening for toxoplasmosis and CMV infection with maternal serology 
during pregnancy is simple, low-cost, and safe but interpretation can be challenging if a blood 
sample is only drawn a long time after infection has occurred[43]. 
The finding of a fetal structural anomaly increases the possibility of a chromosome abnormality 
or genetic molecular defect and should prompt further evaluation into genetic aetiologies[48]. 
Gaglioti et al[22] demonstrated that chromosomal anomalies were found in 10,7% (8/75) of mild 
VM, 2,4% (1/41) of moderate VM and in 3,3% (2/60) of severe VM, the most prevalent being 
Trisomy 21. They concluded that the degree of VM is not predictive of the risk of aneuploidies. 
This is in contrast to Nicolaides et al[49] who reported that the incidence of an abnormal 
karyotype is lower when VM is severe than when it is borderline (mild to moderate). Kennelly 
et al[36] showed that in fetuses with apparently isolated severe VM, the incidence of 
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chromosomal defects was 8,3%. Their conclusion was that karyotyping in cases of severe 
VM, whether isolated or associated with other abnormalities, should strongly be considered. 
Prenatal diagnosis of chromosomal abnormalities is accomplished by invasive techniques, 
such as amniocentesis and chorionic villus sampling (CVS). CVS is performed in the first 
trimester from 10 to 13 weeks, whereas amniocentesis can be performed starting at 15 weeks’ 
gestation[50]. Amniocentesis should be offered to determine the fetal karyotype, as VM is often 
associated with an abnormal karyotype. Chromosomal microarray (CMA) should be offered 
to patients with isolated mild VM and recommended when additional abnormalities are 
detected. CMA has been recommended in the evaluation of fetal anomalies, including VM, 
and can be used as an alternative to fetal karyotype, or as a reflex test following a normal 
karyotype[51]. The yield of CMA is likely higher when VM is associated with other abnormalities.  
Once the antenatal care pathway has been established and the pregnancy is ongoing then 
the delivery and immediate post-natal care of these infants presents another challenge with 
regards to management. It is therefore important that these pregnancies are delivered in a 
tertiary referral centre if immediate paediatric and/or neurosurgical intervention is anticipated.  
Most infants with VM have a normal head circumference; therefore, there is no increased risk 
of cephalopelvic disproportion and poor progress in labour[51]. Yet, VM is at times 
accompanied by macrocephaly, which will require a Caesarean delivery. The cut-off for 
determining when a caesarean delivery is indicated will vary with gestational age at delivery, 
the absolute and relative head circumference and the size of the maternal pelvis. When the 
head circumference exceeds 40cm, abdominal delivery should be considered[51]. Senior 
obstetricians should be involved in these cases and the most appropriate route of delivery 
needs to be determined. With the availability of paediatricians as well as neurosurgeons at 
these centres, early intervention if needed and if appropriate, is possible to optimize 
immediate and long-term outcome. 
In many cases, especially when severe or complex, a very poor prognosis is anticipated and 
the role of TOP needs to be discussed. In the study by Sparey et al[7] overall survival of cases 
of severe VM was 47,9%. The outcome of pregnancies with severe VM is very poor.  In these 
cases, as well as in complex cases involving mild and moderate VM, TOP can be offered. 
 
2.4 Ventriculomegaly in a developing country setting 
2.4.1 General 
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Very little is known about fetal VM in a developing country setting. The majority of studies 
regarding VM are being done in developed countries, where early diagnosis leads to early 
investigation and timely interventions when possible. A major problem in developing countries 
is ‘late booking’, lack of routine ultrasound screening and lack of sufficient expertise leading 
to missed diagnoses or limited/superficial review of these cases. This leads to late diagnosis 
(often after the immediate postnatal period) or staggered and haphazard referrals biased 
towards more severely affected fetuses. In severe or complex cases, this may result in late 
(rather than early) TOP, which can have a major psychological impact on the expecting 
mother. 
2.4.2 Socio-economics 
Congenital anomalies are major causes of neonatal and infant mortality[39]. Socioeconomic 
inequalities in congenital anomalies have been shown to exist in the rates of stillbirth and 
perinatal, neonatal and infant mortality[39]. Socio economic status (SES) have a major 
influence on access to, and timing of, antenatal detection services through the provision of 
information, the interpretation of risk and the consequent decision regarding continuation or 
termination of pregnancy[39]. 
Low-income pregnant women who experience other negative life events (poor housing 
conditions, substance use, lack of social support, child care and transportation) are least likely 
to seek prenatal care[52]. This will then lead to ‘late booking’ or no booking with delay or no 
diagnosis of potential fetal anomalies. 
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Low income may be an indirect determinant of congenital anomalies, with a higher 
frequency among resource-constrained families and countries. It is estimated that 
worldwide about 94% of severe congenital anomalies occur in low- and middle-income 
countries. An indirect determinant, this higher risk relates to a possible lack of access to 
sufficient, nutritious foods by pregnant women, an increased exposure to agents or factors 
such as infection and alcohol, or poorer access to healthcare and screening. Factors often 
associated with lower income may induce or increase the incidence of abnormal prenatal 
development[53]. 
2.4.3 Communicable and infectious diseases 
Several different bodies of evidence support a link between infection and altered brain 
development. Several viral, bacterial and parasitic illnesses are associated with alterations 
in fetal brain structural anomalies including brain calcifications and hydrocephalus[54]. 
The development and maturation of the human brain occur throughout the fetal period and 
is modulated by a set of complex interactions among various signalling receptors, 
genetic/epigenetic factors and environmental influences. The location and timing of insults 
have an important role in cerebral development and, ultimately, function[48]. Maternal HIV 
infection has been consistently and conclusively associated with poor 
neurodevelopmental outcomes, specifically cognitive and neurodevelopmental delays. [54] 
Some congenital viral illnesses produce distinct clinical pathology in fetal brain structure 
and anatomy of varying severity. VZV and CMV are associated with hydrocephalus and 
calcifications[54]. Certain bacterial and parasitic illnesses, similar to viral illnesses, are also 
associated with alterations in brain development. For example, syphilis is associated with 
hydrocephalus, whereas toxoplasmosis is associated with diffuse calcifications in the 
basal ganglia, periventricular calcifications and progressive hydrocephalus[54]. 
Infectious diseases have been a major human enemy in the course of history. The 
situation is worse in the developing countries that are already suffering from poverty, 
hunger, and lack of resources, infrastructure, political stability and will. One may witness 
several such infectious diseases in these parts of the world that hardly exists in today’s 
industrialized countries. In recent decades, trend of greatest burden of infectious diseases 
is observed in remote regions of developing countries[55]. 
2.4.4 Role of invasive testing  
Stellenbosch University https://scholar.sun.ac.za
24 
 
In developing countries and in South Africa particular, the high prevalence of HIV infection 
puts a huge burden on the health care system. More than half of the estimated 33 million 
people in South Africa living with HIV/AIDS are women, and most are of childbearing 
age[56]. The SA Department of Health study estimated that in 2011, 29,5% of pregnant 
women were HIV-positive[57]. 
The use of highly active antiretroviral therapy (HAART) has led to a significant reduction 
in morbidity and mortality from HIV infection and a decline in mother-to-child transmission 
(MTCT)[58]. Before HAART, invasive procedures such as amniocentesis were avoided 
owing to the increased risk of MTCT. Recent literature suggests that it is safe to perform 
amniocentesis in women on HAART with suppressed, preferably undetected, viral loads 
and when transplacental passage of the needle is avoided[59]. 
Unfortunately, in SA many women initiate antenatal care late in pregnancy. All women will 
ideally be offered a fetal abnormality scan between 18 and 22 weeks if resources are 
available. If a fetal abnormality is detected and amniocentesis is offered, there is often 
insufficient time to attain an undetectable viral load within the pre-viability period. [58] 
As clinicians, we have a responsibility to the mother to offer care that is standardized and 
does not discriminate in the presence of HIV infection. However, we also have a 
responsibility to the fetus and should not be exposing that fetus to an unnecessary risk of 
HIV transmission[58]. The risk of possible HIV transmission in women undergoing 
amniocentesis needs to be weighed against the benefits of a prenatal diagnosis. This 
should then be communicated clearly to the patient. Adequate counselling should take 
place, in order for an informed decision to be made[58]. 
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2.5 Conclusion  
Developing countries face many health challenges. Pregnancy related diseases might 
present in a similar way as compared to developed countries. This is true for congenital 
abnormalities as well, but the associations and eventual outcome might differ 
significantly. Especially low socio-economic status, HIV infection, limited resources and 
late initiation of antenatal care are some of the factors that play a significant role in the 
presentation, associations and eventual outcome VM.  Very little is known about VM in 
developing countries and these factors mentioned above are not always as big a 
challenge in developed countries and therefore not always included in studies done. In 
our study we take these factors into account when evaluating the primary and secondary 
outcomes, in order to determine if they play a significant role in the presentation, 
associations and eventual outcome of VM. 
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Chapter 3: Methods 
3.1 Research Design 
3.1.1. Type of study 
This was a retrospective observational study. 
3.1.2. Study setting 
Tygerberg Academic Hospital (TAH) is a secondary and tertiary referral centre in the 
Western Cape Province responsible for the Metro East region of Cape Town and 
designated rural areas, located in Parow, Cape Town. The hospital is the largest hospital 
in the Western Cape and acts as a teaching hospital in conjunction with the University of 
Stellenbosch’s Faculty of Medicine and Health Sciences. It has a catchment population of 
over 2.6 million people. 
3.1.3. Study subjects 
Data was collected from all pregnancies with a prenatal diagnosis of VM noted on the 
Astraia database and the congenital anomaly database from the TAH O&G ultrasound 
unit (SUNCAD) in 2013 to 2015.  
For the purpose of this study, all cases at the O&G ultrasound unit of TAH, with a 
ventricular atrium width of 9.5mm and above were included. This included patients 
referred from the peripheral units, for a fetal anatomical review at TAH. It is possible that 
the measurements of 10mm obtained with old equipment actually included values 
between 9,5 and 10,5mm. No exclusion criteria were used. 
3.2 Data collection 
The principal investigator (PI) extracted all relevant data from the medical records and Astraia 
database file and completed a coded data sheet, reflecting no patient identifiable information. 
This data was then loaded onto a MS Excel database in strictly anonymous fashion. 
3.3 Outcome measures 
3.3.1. Primary outcomes included: 
3.3.1.1. The clinical presentation, associated findings and identified causes of 
ventriculomegaly.  
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3.3.1.2. Natural history and short-term outcomes of fetal VM, including rates of fetal 
loss, spontaneous miscarriage, termination of pregnancy and stillbirth, live birth 
rate, survival to discharge, (very) low birth weight. 
3.3.2. Secondary outcomes included: 
3.3.2.1. Natural history and short term outcomes of “apparently” isolated fetal VM, 
including rates of fetal loss, spontaneous miscarriage, termination of pregnancy 
and stillbirth, live birth rate, survival to discharge, (very) low birth weight. 
3.3.2.2. Maternal morbidity outcomes including preterm labour (onset of labour 
before 37 completed gestational weeks), preterm rupture of membranes 
(rupture of membranes before 37 completed gestational weeks) and mode of 
delivery. 
3.4 Ethics 
The protocol was submitted for local ethical review and was approved by the Health Research 
Ethics Committee of Stellenbosch University (S16/01/016). Individual consent was waived in 
view of this being an anonymous audit. 
3.5 Data analysis and statistical methods 
Statistical analysis was performed with SPSS® Statistics software v24.0. (IBM®, Company). 
A p-value of <0,05 was considered significant. Continuous variables were tested for normal 
distribution by Kolmogorov-Smirnov test and expressed as means with standard deviation 
(SD) or medians with interquartile range. Binomial and ordinal variables were expressed as 
percentage and score, respectively.  
One-way ANOVA with Bonferroni adjusted post-hoc analysis was used to compare normally 
distributed continuous variables and Kruskal-Wallis test for non-normally distributed 
continuous variables. Chi-square test was used for binomial and ordinal variables. Multiple 
logistic regression analysis was used to assess factors associated with “normalization” of atrial 
width. A backward stepwise model was used based on likelihood ratios with an entry and exit 
probability set at 0,05 and 0,1 respectively. 
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Chapter 4: Results 
4.1. Baseline maternal characteristics 
Initially, 258 cases of fetal VM were identified for the time period 1 January 2013 to 31 
December 2015. Upon review of the reports, 6 of these cases were excluded, as it was clear 
that there were data entry mistakes and the fetus did not have VM.  
A final cohort of 252 cases was analysed. The patients were either referred with the 
presumptive diagnosis of VM that was then confirmed, or it was a new finding during an 
assessment for another reason or a finding during a routine assessment in a high-risk patient. 
Complete data could not be obtained in 27,0% (68/252) of cases with 31,0% (52/168) in the 
mild, 19,0% (8/42) in the moderate and 19,0% (8/42) in the severe group, mainly due to 
missing delivery details in 51,9% (27/52), 87,5% (7/8) and 75,0% (6/8) of the mild, moderate 
and severe groups respectively. Other missing data related to details of previous obstetric 
history, medical history as well as booking blood results. Patients were still included in this 
study as long as part of the primary outcome data was available. 
The study flow diagram is depicted in Figure 1. 
 
Figure 1.  Study flow diagram 
The baseline maternal characteristics of all women are depicted in Table 1. The prevalence 
of HIV in this cohort was 18,3% with the highest prevalence of 26,2% (11/42) seen in the 
severe VM group. This was not a significant finding. (p= 0,5).  
Ventrulomegaly cases identified 
n=258
Mild
(≥9,5 - <12mm)
n=168 (66,7%)
Isolated
n=69 (27,4%)
Moderate
(≥12-<15mm)
n=42 (16,7%)
Isolated
n=14 (5,6%)
Severe
(≥15mm)
n=42 (16,7%)
Isolated
n=5 (2,0%)
Excluded
n=6
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Syphilis was noted in 2,8% of the women through routine RPR screening while smoking 
(16,7%) and alcohol use (12,7%) were common in this cohort with 5,2% of women disclosing 
that they used both during the perinatal period. The prevalence of any of these exposures did 
not differ according to VM severity. No women disclosed to using any other recreational drugs 
such as methamphetamine.  
 
Table 1. Maternal characteristics, displayed as median (IQR) or n (% of VM cases), 
according to severity of prenatal VM 
 
All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
p* 
Age (years) 
27,5 (23,7 – 
33,6) 
27,4 (23,6 - 
33,6) 
28,4 (24,5 – 
33,8) 
27,3 (22,9 – 
32,2) 
0,8 
HIV positive 46 (18,3%) 27 (16,1%) 8 (19,0%) 11 (26,2%) 0,5 
RPR# positive 7 (2,8%) 6 (3,6%) 1 (2,4%) - 0,2 
Smoking 42 (16,7%) 30 (17,9%) 9 (21,4%) 3 (7,1%) 0,2 
Alcohol 32 (12,7%) 18 (10,7%) 8 (19,0%) 6 (14,3%) 0,3 
*Kruskal-Wallis (for continuous) or Pearson Chi-Square (for frequencies) test 
#RPR: Rapid plasma reagin 
 
4.2. Obstetric and medical risk profile/history 
The previous obstetrical history is depicted in Table 2 and did not differ with VM severity. Most 
women had at least one previous live birth at term and nobody had a previous fetal 
abnormality. Only 3 (1,2%) women had a previous fetal loss after 24 weeks gestational age, 
but early miscarriage was common (15,1% and equally distributed amongst the groups).  
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Table 2. Previous obstetrical history, displayed as median (IQR) or n (% of VM cases).   
 
All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
p* 
Gravidity 2 (1-4) 3 (1-3) 2 (2-4) 2 (2-4) 0,9 
Parity (≥24w) 1 (0-2) 1 (0-2) 1 (0-2) 1 (1-2) 1,0 
Previous Miscarriage 
(<24w) 
38 (15,1%) 22 (13,1%) 10 (23,8%) 6 (14,3%) 0,8 
Previous fetal abnormality - - - - - 
Previous fetal loss  
(≥ 24w) 
3 (1,2%) 2 (1,2%) - 1 (2,4%) 0,6 
*Kruskal-Wallis (for continuous) or Pearson Chi-Square (for frequencies) test 
From the maternal records, nearly 1 in 15 women (6,3%) were noted to have a medical 
disorder other than HIV. The most prevalent condition was Diabetes Mellitus (DM) with 3,2% 
of all women taking glycaemia reducing medication. Maternal medication use is depicted in 
Table 3.  
 
Table 3. Maternal medication use, displayed as n (% of VM cases). 
 
All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
p 
Diabetic medication 8 (3,2%) 4 (2,4%) 2 (4,8%) 2 (4,8%) 0,6 
Epileptic medication 4 (1,6%) 2 (1,2%) - 2 (4,8%) 0,3 
Warfarin 2 (0,8%) 2 (1,2%) - - NA 
Anti-psychotic 
medication 
2 (0,8%) 2 (1,2%) - - NA 
HAART# 45 (17,9%) 26 (15,5%) 8 (19,0%) 11 (26,2%) 0,3 
*Pearson Chi-Square (for frequencies) test 
#HAART: Highly active antiretroviral therapy 
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4.3. Initial antenatal assessment 
The initial antenatal assessment of the 252 cases with confirmed VM is depicted in Table 4. 
The median gestational age of diagnosis was 165 days (23 weeks 4 days), with 1,6% (4/252) 
diagnosed before 18w0d, 49,6% (125/252) between 18w0d and 23w6d and a “late” diagnosis 
after 24w0d in 48,8% (123/252) of the cases. The gestational age at diagnosis was not 
significantly different between the groups (p=0,08).  
In a total number of 9 cases (6 mild, 1 moderate, 2 severe) it was unclear whether VM was a 
unilateral or bilateral finding, as this was not specified in the Astraia database. Of the 
remaining 243 cases, unilateral VM occurred in 50,2 % and was more frequent in the mild VM 
group (65,4%) while most of the cases of severe VM (92,5%) were bilateral. Mild VM, when 
compared to moderate/severe VM together, was significantly more likely to be unilateral 
(p<0,01) and isolated (p<0,01). 
Table 4. Initial antenatal assessment, displayed as median (IQR) or n (% of VM cases). 
 
All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
P* 
GA at diagnosis (days) 
165 (151-
191) 
163 (150-
187) 
171 (152-
188) 
172 (155-
221) 
0,08 
Largest of the two 
atrial widths (mm) 
11,0 (10,3-
12,7) 
10,5 (10,0-
11,0) 
12,7 (12,2-
13,6) 
20,1 (16,9-
25,9) 
<0,01 
Unilateral VM # 
122/243 
(50,2%) 
106/162 
(65,4%) 
13/41 
(31,7%) 
3/40 (7,5%) <0,01 
Bilateral VM # 
121/243 
(49,8%) 
56/162 
(34,6%) 
28/41 
(68,3%) 
37/40 
(92,5%) 
<0,01 
Isolated finding 88 (34,9%) 69 (41,1%) 14 (33,3%) 5 (11,9%) <0,01 
*Kruskal-Wallis (for continuous) or Pearson Chi-Square (for frequencies) tests across the three 
severity groups. # cases with known data only. 
 
Figure 2 better illustrates the interactions between the symmetry and complexity of VM at 
presentation. 
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Figure 2. Symmetry and complexity of ventriculomegaly at diagnosis 
 
 
4.4. Ventriculomegaly – associated anomalies 
Additional soft markers were noted in 32,7% (55/168), 31,0% (13/42) and 19,0% (8/42) of 
cases of mild, moderate and severe VM respectively (p 0,2).  
A single major anomaly was detected in 20,8% (35/168), 28,6% (12/42) and 38,1% (16/42) of 
cases of mild, moderate and severe VM (p 0,06 for all three, p 0,03 for severe VM compared 
to others) respectively while multiple major anomalies were detected in 4,8% (8/168), 7,1% 
(3/42) and 31,0% (13/42) of cases of mild, moderate and severe VM respectively (p <0,01). 
The structural anomalies diagnosed during the initial ultrasound assessment are depicted in 
Table 5. The majority of major anomalies in all 3 groups were CNS defects in 25,8% (65/252) 
and cardiac anomalies in 10,3% (26/252). The most common CNS defects seen were open 
spina bifida in 9,1% (23/252), cerebellar and vermis dysgenesis in 6,7% (17/252) and corpus 
callosum dysgenesis in 4,4% (11/252). 
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Table 5. Concurrent structural abnormality findings detected during the initial 
ultrasound assessment, displayed as n (% of VM cases). 
 All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
Cardiac: 26 (10,3%) 14 (8,3%) 4 (9,5%) 8 (19,0%) 
 AVSD 8 (3,2%) 5 (3,0%) - 3 (7,1%) 
 DORV 1 (0,4%) 1 (0,6%) - - 
 Interrupted aortic arch 1 (0,4%) - 1 (2,4%) - 
 TGA 1 (0,4%) - - 1 (2,4%) 
 VSD 7 (2,8%) 5 (3,0%) 1 (2,4%) 1 (2,4%) 
 Cardiomegaly 8 (3,2%) 3 (1,8%) 2 (4,8%) 3 (7,1%) 
CNS: 65 (25,8%) 28 (16,7%) 10 (23,8%) 27 (64,3%) 
 Corpus Callosum dysgenesis / 
hypoplasia 
11 (4,4%) 5 (3,0%) 2 (4,8%) 4 (9,5%) 
 CSP abnormalities 3 (1,2%) 2 (1,2%) - 1 (2,4%) 
 Cerebellar and vermis 
dysgenesis 
17 (6,7%) 6 (3,6%) - 11 (26,2%) 
 Dandy Walker malformation 2 (0,8%) 1 (0,6%) - 1 (2,4%) 
 Encephalocele 2 (0,8%) 2 (1,2%)  - 
 Holoprosencephaly 2 (0,8%) - - 2 (4,8%) 
 Open Spina Bifida 23 (9,1%) 9 (5,4%) 6 (14,3%) 8 (19,0%) 
 Schizencephaly 3 (1,2%) 3 (1,8%) - - 
 Microcephaly 1 (0,4%) - 1 (2,4%) - 
 Colpocephaly 1 (0,4%) - 1 (2,4%) - 
Renal: 3 (1,2%) 1 (0,6%) 1 (2,4%) 1 (2,4%) 
 Renal agenesis 3 (1,2%) 1 (0,6%) 1 (2,4%) 1 (2,4%) 
GIT: 3 (1,2%) 3 (1,8%) - - 
 CDH 2 (0,8%) 2 (1,2%) - - 
 Esophageal atresia 1 (0,4%) 1 (0,6%) - - 
Skeletal: 2 (0,8%) - 1 (2,4%) 1 (2,4%) 
 Hemivertebrae 1 (0,4%) - - 1 (2,4%) 
 Skeletal dysplasia 1 (0,4%) - 1 (2,4%) - 
Facial: 5 (2,0%) 2 (1,2%) - 3 (7,1%) 
 Cleft lip/palate 4 (1,6%) 1 (0,6%) - 3 (7,1%) 
 Microphthalmia 1 (0,4%) 1 (0,6%) - - 
Intracranial haemorrhage / 
haematoma 
4 (1,6%) 2 (1,2%) 2 (4,8%) - 
Generalized fetal hydrops 2 (0,8%) 1 (0,6%) 1 (2,4%) - 
     
Stellenbosch University https://scholar.sun.ac.za
34 
 
4.5. Invasive procedures for genetic and infective markers 
Antenatal diagnostic procedures were offered in 59,9% (151/252) of cases; 56,5% (95/168), 
66,7% (28/42) and 66,7% (28/42) of patients with mild, moderate and severe VM respectively 
(p 0,3). Ultimately, 58,3% (88/151) of the patients agreed to undergo invasive testing once 
offered, while 47,4% (45/95), 42,9% (12/28) and 21,4% (6/28) of patients with mild, moderate 
and severe VM respectively declined any further invasive testing (p 0,02 for severe VM 
compared to others). Herein, 40 patients had an amniocentesis, 34 patients a cordocentesis 
and 14 patients had both. This is depicted in Figure 3. 
In 40,1% (101/252) of the women invasive testing was not offered. In the mild VM group, 
83,6% (61/73) of women not offered invasive testing were too advanced in gestation with no 
associated lethal anomalies. The other 16,4% (12/73) were offered TOP without preceding 
invasive testing as they were associated with lethal anomalies or a very poor prognosis. These 
proportions were similar in the moderate VM group, where 78,6% (11/14) of cases were too 
far advanced without any lethal anomalies and 21,4% (3/14) were offered TOP. However, all 
cases (14/14) in the severe VM group who weren’t offered invasive testing already had an 
indication for TOP without requiring confirmatory invasive testing. 
 
Figure 3. Invasive testing offered and procedures performed 
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Of the 88 women who underwent invasive testing, karyotype was requested in 84,1% (74/88) 
while in 15,9% (14/88) invasive testing was only done for infection screening.  
 
4.6.  Genetic test results 
An abnormal prenatal karyotype was detected in 12 cases (4,8% of all cases or 13,6% of 
procedures); 3,6% (6/168) of mild, 2,4% (1/42) of moderate and 11,9% (5/42) of severe VM 
cases (p 0,02 for severe VM compared to others) (Table 6). In those with an abnormal 
karyotype, associated major anomalies were seen in 50,0% (3/6) of mild, none of moderate 
and 83,3% (5/6) of severe VM cases and soft markers in 50,0% (3/6) of mild, 100% (1/1) of 
moderate and 20,0% (1/5) of severe VM cases. As expected, the three most common 
aneuploidies accounted for 66,7% (8/12) of all the abnormal karyotypes. 
 
Table 6. Chromosomal abnormalities from prenatal testing, data displayed as n (% of 
genetic results). 
 
4.7. Infective workup 
An infective workup was performed in 142 patients (56,3% of all cases). Maternal serology for 
Cytomegalovirus was done in 45,2% (114/252) of cases; 53,6% (90/168), 45,2% (19/42) and 
 
All cases 
n=74 
VM 
Mild 
n=42 
VM 
Moderate 
n=14 
VM 
Severe 
n=18 
Common 
Trisomies: 
 
8 (10,8%) 
5 (11,9%) 1 (7,1%) 2 (11,1%) 
 T21 3 (4,1%) 1 (2,4%) 1 (7,1%) 1 (5,6%) 
 T18 3 (4,1%) 2 (4,8%) - 1 (5,6%) 
 T13 2 (2,7%) 2 (4,8%) - - 
Other:     
 22q11.2  1 (1,4%) 1 (2,4%) - - 
 46,XX inv 
dup 7 
1 (1,4%) 
- - 1 (5,6%) 
 45,XX der 
13,18  
1 (1,4%) 
- - 1 (5,6%) 
 47,XX + 9 1 (1,4%) - - 1 (5,6%) 
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11,9% (5/42) of the mild, moderate and severe cases respectively (p < 0,01 for severe VM 
compared to others). No recent infection or perinatal seroconversions were confirmed on 
these results alone.  
Maternal serology for Toxoplasmosis was tested in 52,8% (133/252) of women; 62,5% 
(105/168), 45,2% (19/42) and 21,4% (9/42) of the mild, moderate and severe VM cases 
respectively (p < 0,01 for mild VM compared to others) and also did not reveal any recent 
infection or perinatal seroconversions. 
Invasive testing for infection was performed in 51 cases (38 mild, 7 moderate and 6 severe 
VM) either as part of a meningitis screen PCR on amniotic fluid (including Cytomegalovirus, 
Human Herpes Virus-6, Epstein Barr Virus, Herpes Simplex Virus 1 & 2 and Varicella Zoster 
Virus) or for a CMV PCR on fetal blood. Congenital CMV was confirmed in 5,9% (3/51) of 
these samples (3/252 cases: 1,2%).  
 The first case had mild VM at 30w1d with bilateral periventricular ‘flaring’, irregular 
choroid plexus, septae in posterior horns of lateral ventricles, abnormal cerebellum 
with ‘flat’ hemispheres and calcifications in the cerebellar lobes, a pericardial effusion 
and mildly echogenic bowel with dilated loops of small bowel. Prenatal invasive testing 
(amniocentesis and cordocentesis) revealed a positive fetal CMV PCR, a normal 
karyotype (46,XY), fetal IgM below threshold, platelet count of 107x109/L and AST of 
66U/L. Maternal serum CMV serology only noted CMV IgG positive and IgM negative. 
The possibility of TOP was discussed and offered on the subsequent visit but declined. 
The baby had an uneventful delivery at 37w5d with a 5-minute Apgar score of 9 and 
birth weight of 2140gm (birth weight < p3, in spite of normal umbilical artery Dopplers 
throughout the pregnancy). Details regarding the neonatal period could not be 
retrieved and no confirmatory blood work was done but on a brain ultrasound on day 
3 of life, no clear pathology was noted. The baby was however seen at 1 year of age 
with developmental delay and profound sensory-neural hearing loss for which hearing 
aids were provided. No further follow up notes could be found.  
 The second case was a dichorionic diamniotic (DCDA) twin pregnancy where the 
affected fetus screened high risk (1:6) for T21 due to “apparently isolated” mild VM at 
20 weeks. Amniocentesis and cordocentesis noted a positive fetal CMV PCR, fetal 
IgM below threshold, platelet count of 311x109/L, AST of 64U/L and a normal 
karyotype (46,XX). TOP was offered but the patient chose to continue with the 
pregnancy.  Follow up ultrasounds revealed discordant growth, but review of the 
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anatomy became completely impossible. An emergency caesarean delivery was done 
at 32w0d due to a pathological CTG, related to pre-eclampsia. The affected twin had 
a birth weight of 1850gm and 5-minute Apgar score of 5 and received CPAP for one 
day and nasal prongs oxygen for another four days. CMV retinitis was excluded. By 
day 15, the baby was discharged in good condition but no further follow up notes could 
be traced.  
 The third fetus had severe VM at 32w0d with additional findings of small fused 
cerebellar hemispheres, thromboencephalosynapsis, abnormal cortical development 
of the medial surface of the occipital and parietal lobes with increased subarachnoid 
space in this area, abnormal cavum septum pellucidi and a short corpus callosum with 
a thin posterior part on neurosonography. Amniocentesis was performed and revealed 
congenital CMV infection. In this case the mother opted for TOP with fetocide. On 
cordocentesis a normal karyotype (46,XY) was noted and no post mortem was done. 
4.8. Haemorrhage 
Signs of intracranial haemorrhage were observed in 1,2% (2/168) of mild and 4,8% (2/42) of 
moderate VM.  
 The first case of mild VM was a patient without any medical co-morbidities but 3 
previous caesarean sections. Ultrasound at 23w4d revealed supra and infra tentorial 
haemorrhage. The patient declined invasive testing and fetocide but opted for TOP 
with hysterotomy. Placental histology revealed desidual vasculopathy and edematous 
villi. Fetal autopsy revealed extensive intraparenchymal and intraventricular 
haemorrhage with the epicentre in the fourth ventricle with extensive infarction 
involving the pons, medulla and cerebellum with no clear cause.  
 The second case of haemorrhage with mild VM occurred in a patient on warfarin 
treatment for mixed post-rheumatic mitral valve disease. At the time of diagnosis, her 
INR was therapeutic, ranging between 3,0 - 3,5. A subarachnoid haemorrhage of 
12mm was seen on the left side, lateral to the right sided anterior horn. The patient 
opted for a medical TOP at 23w4d and no autopsy was performed.  
 Both cases of intracranial haemorrhage with moderate VM opted for TOP with fetocide. 
In the first case, ultrasound revealed a large subdural haematoma, compressing and 
displacing the fetal brain. The patient underwent fetocide at 25w3d. Blood results 
showed a normal karyotype but the full blood count and anti-platelet antibodies, to 
exclude rare haematological conditions, failed. No postnatal investigations were done.  
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 The second case was a dichorionic diamniotic twin pregnancy without any anomalies 
noted on the initial ultrasound at 20w4d gestation. At 24w5d however, twin B had 
evidence of a major intracranial haemorrhage, moderate bilateral VM, with echogenic 
material in and around the lateral, 3rd and 4th ventricles. The option of selective fetocide 
was discussed but the patient opted to continue with close observation. At 29w5d 
gestation a fetal MRI demonstrated intracranial periventricular haemorrhage with 
extracellular methaemoglobin, prominent subdural spaces and Sylvian fissures; 
normal grey-white matter differentiation and sulcation in keeping with the gestational 
age. Based on these findings the patient opted for selective TOP with fetocide of the 
affected twin by cordocentesis at 32w5d weeks. Blood results showed a white cell 
count of 1,73x109/L, platelet count of 33x109/L, smear result of reduced platelets, 
leukopenia and toxic granulation, total IgM <0,25. The patient presented with 
spontaneous preterm labour at 34 weeks, resulting in an emergency caesarean 
section for breech presentation. The surviving co-twin had a birth weight of 2110gm 
with a 5-minute Apgar score of 9 and had an uneventful neonatal course.  
 
4.9. Ventricle dimensions – antenatal trends 
 
Of the initial 252 patients, 45 underwent TOP after the first assessment (17,9%) and 49 never 
returned (19,4%), leaving 158 women (62,7%) with follow up antenatal scans, including 72,0% 
(121/168) of the mild, 59,5% (25/42) of the moderate and 28,6% (12/42) of the severe group 
(p < 0.01). Of these 121 mild VM cases, 39,3% (66/168) “normalised” to a measurement of 
less than 10mm while 6 progressed to moderate (5,0% of mild VM follow ups, 3,6% of all mild 
VM cases) and 5 to severe (4,1% of mild VM follow ups; 3,0% of all mild VM cases) and the 
remaining 44 cases remained mild.  A similar trend of “regression” was seen in the moderate 
VM cases that followed up, with 56,0% (14/25) having subsequently smaller atrial width than 
at the initial diagnosis and 24,0% (6/25) of them “normalised” to below the cut-off of 10mm; 
12,0% (3/25) progressed to severe VM.  In only three severe VM cases were the subsequent 
measurements smaller than the initial assessment but none were below 15mm. Figure 4 
depicts the progression of the mild and moderate VM groups with follow up data.  
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Figure 4. Progression in the mild and moderate VM group, displaying the difference 
between the last and initial atrial width measurement. 
 
Exceptional cases: As can be seen from Figure 4, 3 cases had substantial progression, i.e. 
more than 5mm increase in subsequent measurements.  
 The first case was a poorly controlled epileptic who was using Carbamazepine, 
Sodium Valproate and Lamotrigine. The ultrasound examination at 20w6d showed 
mild unilateral VM with an abnormal cavum septum pellucidum (CSP) and agenesis of 
the corpus callosum. The patient declined any invasive testing and on subsequent 
assessment the VM progressed to bilateral severe VM with a largest diameter of 
22,7mm. The patient had a caesarean section for failed induction of labour at 41 
weeks. The birth weight was 3680gm with a 5-minute Apgar of 10. A postnatal cranial 
ultrasound confirmed an absent corpus callosum and the VM. The baby was 
discharged in good condition on day 6 but did not follow up for the planned genetic 
and neurology review. 
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 The second case involved a dichorionic diamniotic twin pregnancy in an epileptic 
patient, using Carbamazepine and Phenytoin. At 18 weeks, open spina bifida, 
myelomeningocele and Arnold Chiari malformation were noted but with normal 
ventricles. She declined TOP and no invasive testing was offered as the anti-epileptic 
medication was presumed to be the likely cause for the neural tube defect.. The VM 
progressed to bilateral severe VM with a final largest diameter of 25mm. The patient 
went into spontaneous preterm labour at 36 weeks and the birth weight of the affected 
twin was 2160gm, with a 5 minute Apgar of 9. The myelomeningocele was repaired 
on day 2 of life and a VP shunt was placed at 6 weeks of age. The baby had an 
uneventful course until discharge, but no further follow up could be traced.  
 The third case was a 37-year-old woman who had a diagnostic cordocentesis for 
isolated mild bilateral hydronephrosis at 20w0d, resulting in an adjusted risk for Down 
syndrome of 1:199. The karyotype was normal (46,XY) but at 22 weeks, on review of 
the hydronephrosis, bilateral moderate VM was noted. The patient declined TOP and 
the VM worsened with advancing gestation, the largest diameter being 21mm. A fetal 
MRI at 26 weeks showed delayed cortical development, eventually resulting in the 
parents opting for late TOP with fetocide at 29 weeks’ gestation. No postnatal 
investigations were done.  
 
When reflecting exclusively on evolution in the 88 cases of “apparently isolated VM” a higher 
resolution trend was noted in the mild VM group (62,3%) with none of the cases in this 
subgroup progressing to severe VM, while none of the severe VM cases showed resolution. 
 
Lastly, 35 patients presented with initial “borderline” measurements between 9,5 – 9,9mm and 
subsequent measurements were recorded in 31 cases: 67,7% (21/31) normalized to below 
9,5mm, 12,9% (4/31) remained stable, 16,1% (5/31) progressed to more than 10mm and 3,2% 
(1/31) progressed to moderate VM. Of the 17 borderline cases without associated anomalies, 
sixteen had follow up scans and 68,8% (11/16) resolved, 12,5% (2/16) remained stable and 
18,8% (3/16) progressed to more than 10 mm. 
4.10. Pregnancy outcomes 
4.10.1. General outcomes (n=252) 
The delivery outcomes of this cohort are depicted in Table 7. The spontaneous PTB rate, 
before 37 weeks, was 6,3% (16/252); being 7,1% (12/168), 2,4% (1/42) and 7,1% (3/42) 
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for the mild, moderate and severe VM groups respectively. However, the overall PTB rate, 
excluding the TOP cases, was 21,4% (54/252). 
 
Table 7. Delivery outcomes, displayed as median (IQR) or n (% of total VM cases in group) 
 All cases 
n=252 
VM 
Mild 
n=168 
VM 
Moderate 
n=42 
VM 
Severe 
n=42 
p* 
GA at delivery (days) 246 (193-269) 256 (219-271) 219 (173-267) 216 (165-257) 0,005* 
TOP 61 21 15 25  
Spt IUFD 8 4 3 1  
Delivery mode      
 Spontaneous NVD 49 (19,4%) 38 (22,6%) 8 (19,0%) 3 (7,1%) 0,08 
 Induced NVD 74 (29,4%) 32 (19,0%) 17 (40,5%) 25 (59,5%) <0,001 
 Elective CD 18 (7,1%) 15 (8,9%) 2 (4,8%) 1 (2,4%) 0,1 
 Emergency CD 50 (19,8%) 35 (20,8%) 8 (19,0%) 7 (16,7%) 0,8 
 Unknown 61 (24,2%) 48 (28,6%) 7 (16,7%) 6 (14,3%) 0,07 
Live borns  122 95 18 9  
 Birth weight (g) 2620 
(840-4500) 
2650 
(840-4120) 
2785 
(1050-4500) 
2300 
(1340-4010) 
0,42 
 Apgars 9 (1-10) 9 (1-10) 9 (4-10) 9 (7-10) 0,92 
*Kruskal-Wallis (for continuous) or Pearson Chi-Square (for frequencies) test 
Perinatal outcomes were known in 76,2% of cases (192/252): 71,4% (120/168) of mild, 85,7% 
(36/42) of moderate and 85,7% (36/42) of severe VM (Figure 5).  
There were no cases reported of spontaneous miscarriage and only one early neonatal death. 
This particular patient had a fetus with a low open spina bifida and severe VM. She presented 
in spontaneous preterm labour at 35w6d, with a breech presentation and delivered by 
caesarean section. The baby weighed 2690gm, had grade 3 meconium stained liquor and a 
5-minute Apgar score of 1. The baby did not qualify for NICU care and received only palliative 
care in view of the antenatal findings, resulting in demise.  
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Figure 5: Perinatal outcomes 
 
*TOP – termination of pregnancy 
4.10.2. Termination of pregnancy (n=61) 
TOP was offered to 102 women (43 mild, 19 moderate and 40 severe VM cases).  Sixty-
one women opted for TOP (24,2%) including 12,5% (21/168) of mild, 35,7% (15/42) of 
moderate and 59,5% (25/42) of the severe VM cases (p <0,001). Fetocide was performed 
in 28,6% (6/21), 40,0% (6/15) and 64,0% (16/25) of TOPs for mild, moderate and severe 
VM respectively. The initial presentation and associations of the cases resulting in TOP 
are depicted in Table 8. 
 
Table 8. Prenatal associations in TOP cases 
Prenatal VM 
Associations 
All TOP TOP without Fetocide 
n = 33 
TOP with Fetocide 
n = 28 
None i.e. 
Isolated 
Mild: 0/21 
Mod: 3/15 
Severe: 2/25 
Mild VM: 0/15 
Mod VM 3/9 
Severe VM: 0/9 
Mild VM: 0/6 
Mod VM: 0/6 
Severe VM: 2/16 
Additional soft 
markers only  
Mild: 4/21 
Mod: 2/15 (*1) 
Sev: 4/25 (*2) 
Mild VM: 2/15 
Mod VM: 1/9 
Severe VM: 2/9  
Mild VM: 2/6 
Mod VM: 1/6 
Severe VM: 2/16 
Major 
structural 
anomalies 
Mild:17/21 (*1) 
Mod:10/15 
Sev: 19/25 (*3) 
Mild VM 13/15 
Mod VM 5/9 
Severe VM 7/9 
Mild VM 4/6 
Mod VM 5/6 
Severe VM 12/16 
48
6 6
95
18
9
15
9
9
6
6
16
4 3 11
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Unknown Live birth TOP TOP with fetocide Stillbirth Early neonatal death
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Abnormal 
karyotype 
Mild: 1/21 
Mod:1/15 
Sev: 5/25 
Mild VM 0/15 
Mod VM 1/9 
Severe VM 2/9 
Mild VM 1/6 
Mod VM 0/6 
Severe VM 3/16 
(N*) N with abnormal karyotype 
Amongst the 21 TOPs for mild VM, 81,0% (17/21) of cases had associated major 
anomalies. The anomalies included mostly CNS (n=11) and cardiac (n=4) anomalies and 
one Trisomy 13 out of 6 karyotypes. All major anomalies were regarded to have a poor 
prognosis. In 4 cases, only multiple soft markers were noted and invasive testing was 
accepted in 3 noting normal karyotypes and negative infective work up.  All four cases 
screened high for aneuploidy. The first case was diagnosed at 17 weeks. The corpus 
callosum could not be identified due to position of fetal head. The second case was 
diagnosed at 21w4d. Follow up ultrasound two weeks later revealed cerebellar hypoplasia. 
The third case was diagnosed at 23 weeks gestation. The mother was of advanced 
maternal age. The fourth case was diagnosed at 23 weeks gestation. Follow up ultrasound 
two weeks later revealed very abnormal Dopplers (AEDF) with subsequent hypertension, 
and thus the diagnosis of pre-eclampsia was made.  
Overall, karyotyping was performed in 42,9% (9/21) of the mild VM cases who accepted 
TOP and a single case of Trisomy 13 was diagnosed.   
Amongst the 15 TOPs for moderate VM, 66,7% (10/15) of cases had associated major 
anomalies that comprised almost exclusively of the CNS (n=8). The three isolated cases 
of moderate VM will be discussed in the next section. Karyotyping was performed in 53,3% 
(8/15) of moderate VM cases who accepted TOP and only one case of Trisomy 21 was 
diagnosed.  
Amongst the 25 TOPs for severe VM, 76,0% (19/25) had associated major anomalies and 
half of these comprised of multiple structural anomalies (n=10/19).  In 4 of the remaining 
6 cases only multiple soft markers were noted, one of which was associated with Trisomy 
21. In the remaining 2 cases, there were no clear antenatal associations found. 
Karyotyping was performed in 64,0% (16/25) of severe VM cases accepting TOP and an 
abnormal karyotype was found in 5 cases (Table 6 & 8). 
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4.10.3. Borderline cases (n=35) 
Of the borderline VM cases, 12 (34,3%) were associated with multiple soft markers, 6 
(17,1%) with major anomalies and 17 (48,6%) had no associated anomalies. Genetic 
testing was done in 10 cases (28,6%) and abnormal in 2 cases (5,7%; one Trisomy 21, 
one Di George syndrome). The Trisomy 21 case had soft markers only and the Di George 
syndrome had a large VSD. Only one case in this subgroup had a confirmed CMV infection 
(the DCDA twin pregnancy discussed in section 4.7). In 25,7% (9/35) the outcome was 
not known and the remainder were live born, apart from two cases resulting in TOP. The 
first case was for severe intracranial haemorrhage secondary to warfarin treatment for 
mixed mitral valve disease. The second case was for non-immune hydrops fetalis, with 
multiple soft markers at 22 weeks’ gestation, negative infective work up and normal 
karyotype but with a guarded prognosis. Of the 17 borderline cases without associated 
anomalies, none had infection or an abnormal genetic result.  
 
4.10.4. “Apparently isolated” cases (n=88) 
When reflecting exclusively on the overall outcome of 88 cases of apparently isolated VM 
(Table 9) none were associated with an abnormal karyotype or confirmed congenital 
infection and 17,0% (15/88) could be discharged back to their referring institution after 
resolution/normalisation.   
Yet, in 5,7% (5/88) the pregnancy ended in a TOP (3 moderate VM, 2 severe VM cases).  
 The first TOP was for a patient with chronic hypertension, moderate VM and 
severe IUGR at 20 weeks’ gestation.  
 The second TOP was in a patient with well controlled DM, epilepsy and chronic 
hypertension, but moderate VM at 22 weeks’ gestation.  
 The third TOP was in a healthy woman, who gave history of a rash two weeks prior 
to ultrasound. Moderate VM at 21 weeks was diagnosed and TOP was accepted. 
 The fourth TOP was for a morbidly obese patient who booked late and had severe 
VM at 33 weeks  
 The fifth TOP was in a healthy woman with severe fetal VM diagnosed at 27 weeks’ 
gestation and persisting on follow up scans. After consulting with the paediatric 
neurologist the woman opted for TOP with fetocide at 30 weeks’ gestation. 
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Table 9. Outcomes of apparently isolated VM cases displayed as median (IQR) or n (% of 
cases in the group). 
 
All cases 
n=88 
VM 
Mild 
n=69 
VM 
Moderate 
n=14 
VM 
Severe 
n=5 
p* 
GA at diagnosis (days) 168 (151-194) 164 (150-194) 163 (149-193) 236 (204-251) 0,06 
Bilateral 30 (34,1%) 17 (24,6%) 10 (71,4%) 3 (60,0%) 0,003 
Ventricle diameter (mm)      
 At diagnosis 
10,7 (10,1-
11,6) 
10,5 (10,0-
10,8) 
12,7 (12,3-
13,0) 
24,1 (20,4-
37,6) 
<0,01 
 At last visit 9,9 (8,2-11,0) 9,3 (8,0-10,4) 
12,4 (10,6-
13,3) 
23,4 (19,5-
37,3) 
<0,01 
Natural history      
 Resolved (<10mm) 46 (52,3%) 43 (62,3%) 3 (21,4%) 0 <0,01 
 Persisted (in same 
category) 
41 (46,6%) 26 (37,7%) 10 (71,4%) 5 (100,0%) 0,06 
 Progressed to severe 
VM 
1 (1,1%) 0 1 (7,1%) NA 0,200 
Outcome      
 Unknown 32 (36,4%) 29 (42,0%) 2 (14,3%) 1 (20,0%) 0,2 
 TOP (± feticide) 5 (5,7%) - 3 (21,4%) 2 (40,0%) 0,6 
 Stillbirth - - - -  
 Live born 51 (58,0%) 40 (58,0%) 9 (64,3%) 2 (40,0%) 0,6 
 Early neonatal death - - - -  
*Kruskal-Wallis (for continuous) or Pearson Chi-Square (for frequencies) test 
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Chapter 5: Conclusion 
5.1. Summary of main findings 
The median gestational age at diagnosis was 23w4d, with 48,8% diagnosed after 24w0d. 
There were no maternal predictors identified; the maternal characteristics as well as the 
obstetric and medical risk profile did not differ with VM severity. Mild VM was more likely 
to be unilateral (p<0,01) and isolated (p<0,01) when compared to moderate and severe 
VM. Mild VM was associated with multiple soft markers in up to a third of the cases and 
over half of the cases normalized during pregnancy; severe VM was associated with 
multiple major anomalies in 31,0% of the cases. The majority of major anomalies in all 3 
groups were CNS defects in 25,8% and cardiac anomalies in 10,3%. Termination of 
pregnancy was opted for in 12,5% of mild, 35,7% of moderate and 59,5% of severe VM 
cases.  
 
5.2. General discussion 
In almost half of the patients, the diagnosis was made after 24w0d when offering of TOP 
becomes more restrictive and TOP requires fetocide. Although not specifically 
investigated in this study, this can at least partly be attributed to late initiation of antenatal 
care. The WHO recommends initiation of ANC during the first trimester but far later first 
ANC presentation remains widespread in sub-Saharan Africa. Lack of education, 
attitudes, knowledge regarding pregnancy, cultural beliefs, availability, affordability and 
accessibility of health care services all contribute to delay in ANC initiation. A recent cross-
sectional study done by Ebonwu et al[60] in South Africa showed that unplanned 
pregnancies, teenage pregnancies and being married all contributed to late initiation of 
ANC.  
Mild VM, when compared to moderate/severe VM, was more likely to be unilateral 
(p<0,01) and in our study, almost half of all the cases of VM, 48,4% (122/252) were 
unilateral VM. This differs from international literature where most researchers agree that 
unilateral VM is rare, resulting in research series that are small[19]. A possible explanation 
for our findings is that older studies assumed bilateral VM whenever VM was diagnosed, 
as it was not the custom to routinely measure the most proximal hemisphere that is 
obscured by acoustic shadowing. In our unit, we make an effort to change the transducer 
or fetal position to allow visualization of both hemispheres. An alternative explanation is 
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the inclusion of borderline cases in our series, which may not have formed part of other 
studies.  
The majority of studies reporting the perinatal and long-term outcomes in fetuses with an 
antenatal diagnosis of fetal VM have assessed the bilateral condition[61]. Kinzler et al and 
Durfee et al both agree that fetuses with asymmetrical unilateral VM have a better 
prognosis than those with bilateral VM[20,21]. 
 
5.3. Associations and population risk profile 
Mild VM, when compared to moderate/severe VM, was more likely to be isolated (p<0,01). 
Once the diagnosis of VM is made, a rigorous search for associated anomalies should be 
done, because VM is frequently associated with other anomalies. Follow up assessment 
is extremely important, as anomalies may manifest only later on during the pregnancy. 
The most common major structural anomalies in all 3 groups of this study were CNS 
defects in 25,8% and cardiac anomalies in 10,3% in line with Sethna et al [35] who reported 
31,8% (113/355) CNS anomalies and 3,9% (14/355) cardiac anomalies in 355 cases of 
mild and moderate VM respectively. The most common CNS defects seen in the current 
study were open spina bifida and cerebellar and vermis dysgenesis, in line with Sethna 
(spina bifida and absence of the corpus callosum). A striking difference between this study 
and studies from developed countries is the limited use of MRI to search for more 
anomalies not seen on ultrasound. Limited access and cost prevent use of MRI in most 
cases and therefore it is only used in selected cases. 
 
Aneuploidy was associated with VM (4,8%; 12/252) but mainly limited to cases with 
associated ultrasound findings (in 9/12). Our incidence was lower than reported by Gaglioti 
et al (>15% when severe or borderline VM is associated with structural malformations)[18] 
or Sethna[35] (11,0% on prenatal karyotype, increasing to 14,1% when post-natal 
karyotypes were included). It is likely that the low incidence of abnormal karyotype in our 
study is due to the fact that only 74 cases (i.e. less than a third) had prenatal genetic 
testing (but it was offered to almost 60% of patients) and post-natal karyotype results were 
not reviewed. Of the ones that were tested, the abnormal yield of 16,2% (12/74) was more 
in line with the other studies.  
The three most common aneuploidies accounted for 66,7% of all abnormal karyotypes. 
Trisomy 21 & 18 were the commonest aneuploidies overall. Consistent with data from 
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Lam[24] and Gaglioti[18] the severity of VM is not predictive of the risk of aneuploidy. In our 
study more cases of aneuploidy were seen in the mild VM group as compared to moderate 
and severe VM. 
 
5.4. Evolution of VM 
The importance of follow up assessment is clearly demonstrated in this study. It is well 
known from the literature that VM can remain stable, show progression or regression. As 
can be seen in Figure 4, the trend of progression or regression in the mild and moderate 
groups is demonstrated. 54,5% (66/121) of mild VM cases that had follow up scans, 
showed regression and in the moderate group 24% of cases that had follow up scans, 
‘normalized’ to below the cut off of 10mm. In the severe group, only 3 cases had smaller 
measurements, but none were below 15mm. This is consistent with findings by Lam et 
al[24] who found the rate of regression in mild and moderate VM to be 46% and 26% 
respectively. They confirmed that when ventricles exceed 15mm, they do not tend to 
normalize. It is clear from this study that the rate of progression of VM increases with 
severity and that resolution in severe VM is unlikely to occur. 
5.5. Acceptance rates 
5.5.1. Acceptance rates of invasive testing 
The main reason for declining invasive testing was the fear of a possible miscarriage 
associated with the procedure. This is quoted as less than 1%. Lack of education and poor 
understanding contribute to this. Another reason for declining invasive testing is religion. 
Patients will not consider TOP under any circumstances and will accept a child irrespective 
of the diagnosis or prognosis, based on their religious beliefs.  
5.5.2. Acceptance rates of TOP 
TOP was accepted in 24,2% (61/252). The study demonstrated that rates of termination 
increased with severity of VM, as can be seen in Figure 5. This is consistent with data 
from Lam et al. [24] They found that TOP was done in 25%, 53% and 72% of mild, moderate 
and severe VM respectively. One explanation for acceptance of TOP in the current study 
is that patients from a developing country and low SES don’t have the financial capacity 
to care for infants with special needs and poor neurological outcome if they do survive. 
Stellenbosch University https://scholar.sun.ac.za
49 
 
Provision of and access to rehabilitation services are limited and the financial implications 
play a major role.  
The diagnosis of fetal anomaly triggers intense distress and discomfort in the expecting 
mother regardless of severity[62]. Counselling plays an important role regarding the 
decision of the mother to undergo a TOP. At our unit, counselling focuses on the five key 
aspects that are the basis for understanding fetal prognosis[63]. This includes but are not 
limited to diagnosis and certainty thereof, likelihood of survival beyond neonatal period, 
likely duration of survival if life-sustaining treatment is provided, range of possible physical 
and cognitive impairments if the new-born survives and the burden of treatment required 
to keep the baby alive. Non-directive counselling is provided so that patients can have a 
clear understanding of VM as well as the poor outcome associated with increasing 
severity, but patient autonomy is always respected.  
 
5.6 “Apparently isolated” cases 
88 cases of ‘apparently isolated’ VM were identified, the majority being in the mild VM 
group. 62,3% of the mild cases resolved. The diagnosis of isolated VM should only be 
made after having carried out a complete and rigorous ultrasound search for associated 
intracerebral and extracerebral anomalies[17]. The use of MRI, if available, can play an 
important role in diagnosing associated anomalies not seen on ultrasound. In developing 
countries, this should be on a case-to-case basis only, as cost limits its use. In our study, 
the isolated cases were considered truly isolated, as follow up ultrasound assessment 
were available in all these cases. 
Isolated mild VM represents a considerable diagnostic dilemma as it can be seen as a 
variation of normality, but still is associated with chromosomal abnormalities, congenital 
infections, cerebral vascular accidents or haemorrhage and other fetal cerebral and 
extracerebral abnormalities in some cases. It may also have implications regarding long-
term neurodevelopmental outcome. [12] It is thus imperative to follow up these ‘apparently 
isolated’ cases after the diagnosis is made, as associated anomalies may appear later on 
with advancing gestation and the truly isolated cases are not ‘innocent’ or less important 
compared to those cases with associated findings. As seen in Table 9, in 58,0% (40/69) 
of mild isolated VM the outcome was a live born infant. 42,0% (29/69) of mild cases were 
lost to follow up; the reason therefore can be twofold, namely they were truly lost to follow 
up or the VM normalized and the patients were discharged from TBH.  
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Progression/Non-progression in isolated cases 
None of the mild isolated cases progressed to moderate or severe VM. Only one case of 
moderate VM progressed to severe VM. This is in contrast to the study done by Quahba 
et al[17] follow up scans in 167 fetuses with mild isolated VM showed progression in 11% 
of cases, but they made use of MRI as a complementary investigation to ultrasound. 
Infants with progression were at higher risk of subsequent neurodevelopmental delay that 
those with no progression. In our study we didn’t consider neurodevelopmental outcome, 
but it is well known from the literature that in non-progressive isolated VM the prognosis 
seems better and the rate of normal post-natal development is still higher if VM resolves 
antenatally[17]. 
 
Chromosomal abnormalities in isolated VM 
A literature review done by Kelly et al[25] showed that the incidence of chromosomal 
abnormalities varied from 3% to 12,6% in fetuses with mild VM. In our study, none of the 
isolated cases (mild, moderate and severe isolated VM) that were tested had an abnormal 
karyotype. We acknowledge that only 21,6% (19/88) of the isolated cases had karyotyping 
done, that could have contributed to the result. Invasive testing is offered to patients who 
screens high risk for aneuploidy based on their background risk as well as ultrasound 
findings. Currently we don’t offer serum screening during the first or second trimester. This 
can probably influence the uptake of invasive testing that will lead to more cases of 
aneuploidy being diagnosed.  
 
Isolated VM and TOP 
Quahba et al[17] reported a TOP rate for isolated mild VM of 3,5% when truly isolated mild 
VM were considered. In our study, the overall TOP rate was 5,7% (5/88); none of the 
known outcomes of mild VM ended in TOP whereas 21,4% (3/14) of moderate VM and 
40,0% (2/5) of severe VM underwent TOP. The decision for TOP for isolated moderate 
and severe VM is easier as it is known that increasing severity of VM is associated with 
poor neurodevelopmental outcome. For mild isolated VM it remains a difficult decision. 
Vigorous search for associated anomalies that may appear only later on, progression of 
VM, invasive testing for aneuploidy and testing for fetal infections can all contribute and 
aid in the decision-making regarding TOP in mild cases.  
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5.7 Borderline measurements 
The majority of the literature and studies on VM are limited to measurements ≥10mm. As 
mentioned earlier, VM with a measurement of 10mm can actually be measurements 
ranging between 9,5-10,5mm due to older equipment being used. We identified a 
subgroup of 35 patients with mild VM, with initial measurements of 9,5-9,9mm. More than 
half of these cases had associated anomalies. As seen from our study, this is not a ‘benign’ 
group of cases: 34,3% had soft markers and 17,1% had major anomalies. 12,9% remained 
stable and 19,4% progressed to a measurement of more than 10mm. It can be associated 
with poor outcomes, even if they normalize or remain stable. It is thus important that this 
subgroup of patients is followed up closely to look for progression, regression and 
associated anomalies that are only apparent at a later gestational age, as this can have a 
major impact on the initial and long-term outcome.  
 
5.8 Limitations of the study 
The study has several limitations. As with retrospective studies based in a referral centre, 
the findings do not necessarily represent the population. Significant selection bias is likely, 
with more severe cases more likely being suspected and referred. Incomplete medical 
records as well as the high rate of loss to follow up could’ve had an impact on some of the 
results. Long-term neurological outcome was not assessed so no comparison is possible 
with data from developed countries to assess similarities as well as significant differences.  
 
5.9 Strengths of the study 
This is the first detailed report of VM from a developing country. According to the 
investigators’ knowledge, it is the first study from a South African perspective. It gives a 
detailed account of pregnancies referred for VM in a defined geographical area of South 
Africa with a fairly well established obstetric ultrasound service and access to special 
investigations. Another strength of our study is that we were able to stratify according to 
the degree of VM in three separate categories with distinct clinical differences. The 
number of “apparently isolated” cases was sufficient to enable comments on a number of 
key outcomes and the subgroup analysis on borderline cases (9,5-9,9mm) provided 
clinically useful additional information.  
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5.10 Conclusion and future directions 
Conclusion 
VM is not an uncommon prenatal finding but, in this setting, was often diagnosed late, 
which limits options for investigation and management. Associated findings, esp. cardiac 
and CNS, were common and increased with increasing severity of VM but aneuploidy 
occurred with any severity. In this cohort, unilateral VM was associated with mild VM and 
may have been due to the inclusion of borderline VM, which was shown not to be a benign 
finding. Uptake of invasive testing and of TOP was low in this community, and late 
diagnosis may have contributed to that.  
 
Future directions 
Future research can include long-term postnatal neurodevelopment, specifically in relation 
to VM severity and progression as well as apparently isolated VM. This will aid in 
counselling of expectant parents regarding this challenging diagnosis, prognosis and its 
management options. 
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